SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000875320-17-000047
Filing Date
2017-07-28
Accepted
2017-07-28 16:23:20
Documents
84
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2017q210-q.htm 10-Q 1633818
2 EXHIBIT 3.1 a2017q210-qexhibit311.htm EX-3.1 287788
3 EXHIBIT 3.2 a2017q210-qexhibit321.htm EX-3.2 113671
4 EXHIBIT 31.1 a2017q210-q_exhibit311.htm EX-31.1 14548
5 EXHIBIT 31.2 a2017q210-q_exhibit312.htm EX-31.2 14407
6 EXHIBIT 32.1 a2017q210-q_exhibit321.htm EX-32.1 11922
  Complete submission text file 0000875320-17-000047.txt   9495730

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT vrtx-20170630.xml EX-101.INS 2174197
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrtx-20170630.xsd EX-101.SCH 67110
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrtx-20170630_cal.xml EX-101.CAL 98899
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrtx-20170630_def.xml EX-101.DEF 362761
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrtx-20170630_lab.xml EX-101.LAB 798582
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrtx-20170630_pre.xml EX-101.PRE 506042
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19319 | Film No.: 17990297
SIC: 2834 Pharmaceutical Preparations